retatrutide ly3437943 triple agonist glp-1 gip glucagon Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide | GLP-1R/GIPR/GCGR ligand |
Description
While this has not been confirmed in humans, you should tell your provider if you notice a lump or swelling in your neck, hoarseness, difficulty swallowing, or persistent shortness of breath
A thorough medical evaluation is needed to determine if this treatment is a safe and effective choice for you
2023;108(7):e431-e445
*FOR WEIGHT-LOSS MEDICATION BMI SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)
That is not changing any time soon
